These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 894100

  • 21. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C, Brissot P, Messner M, Delamaire D, Gie S, Bourel M.
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Assessment of liver function by the aminopyrine breath test.
    Villeneuve JP, Arsène D, Huet PM.
    Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
    [Abstract] [Full Text] [Related]

  • 28. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES, Passananti GT, Glenwright PA, Dvorchik BH.
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [Abstract] [Full Text] [Related]

  • 29. Proceedings: The relationships between liver volume and the disposition of antipyrine and indocyanine green before and after phenobarbitone treatment.
    Branch RA, Halliwell M, Jackson L, Roberts CJ.
    Br J Pharmacol; 1975 Oct; 55(2):263P. PubMed ID: 1201403
    [No Abstract] [Full Text] [Related]

  • 30. Drug disposition in patients with HBsAg-positive chronic liver disease.
    Villeneuve JP, Thibeault MJ, Ampelas M, Fortunet-Fouin H, LaMarre L, Côté J, Pomier-Layrargues G, Huet PM.
    Dig Dis Sci; 1987 Jul; 32(7):710-4. PubMed ID: 3595383
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Factors influencing diazepam pharmacokinetics: age, sex, and liver disease.
    Greenblatt DJ, Harmatz JS, Shader RI.
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):177-9. PubMed ID: 649236
    [Abstract] [Full Text] [Related]

  • 36. Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.
    Hayes PC, Bouchier IA.
    Am J Gastroenterol; 1989 Jul; 84(7):723-6. PubMed ID: 2741882
    [Abstract] [Full Text] [Related]

  • 37. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans.
    Cousins MJ, Gourlay GK, Knights KM, Hall PD, Lunam CA, O'Brien P.
    Anesth Analg; 1987 Apr; 66(4):299-308. PubMed ID: 3565792
    [Abstract] [Full Text] [Related]

  • 38. [Experiences with the 14C-aminopyrine breath test in liver cirrhosis and under the effect of sodium diclofenac (Voltaren)].
    Reinicke C, Eitner K, Hippius M, Krombholz B, Stiller KJ, Wächter G.
    Dtsch Z Verdau Stoffwechselkr; 1983 Apr; 43(3):117-29. PubMed ID: 6603964
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.